Expert Opinion on Drug Delivery

Papers
(The H4-Index of Expert Opinion on Drug Delivery is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Metallic nanoparticles as drug delivery system for the treatment of cancer68
Microneedle arrays for the treatment of chronic wounds67
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery66
Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities61
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action60
Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update54
Advances in lyotropic liquid crystal systems for skin drug delivery50
Release mechanisms and applications of drug delivery systems for extended-release50
The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis49
Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?47
Wound dressings as growth factor delivery platforms for chronic wound healing44
A review of recent advances in nanodiamond-mediated drug delivery in cancer41
Manipulative magnetic nanomedicine: the future of COVID-19 pandemic/endemic therapy40
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance40
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation38
Surface-modified polymeric nanoparticles for drug delivery to cancer cells38
Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis38
Emerging potential of niosomes in ocular delivery37
Electrospun nanofiber-based drug delivery platform: advances in diabetic foot ulcer management37
Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease37
Nose-to-brain delivery of antipsychotics using nanotechnology: a review36
Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells36
Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer35
Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies35
Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans35
Penetratin-modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration35
Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung34
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection34
Clay nanoparticles as pharmaceutical carriers in drug delivery systems33
Orally administered self-emulsifying drug delivery system in disease management: advancement and patents33
The perspectives of intra-articular therapy in the management of osteoarthritis33
Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy33
Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer33
0.074965953826904